Cart
sales@molnova.com
PD128907 HCl
CAS No. 112960-16-4
PD128907 HCl ( —— )
Catalog No. M17150 CAS No. 112960-16-4
PD 128907 HCl is a potent and selective dopamine D3 receptor agonist, with EC50 of 0.64 nM, exhibits 53-fold selectivity over dopamine D2 receptor.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 96 | Get Quote |
|
| 10MG | 149 | Get Quote |
|
| 25MG | 250 | Get Quote |
|
| 50MG | 372 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePD128907 HCl
-
NoteResearch use only, not for human use.
-
Brief DescriptionPD 128907 HCl is a potent and selective dopamine D3 receptor agonist, with EC50 of 0.64 nM, exhibits 53-fold selectivity over dopamine D2 receptor.
-
DescriptionPD 128907 HCl is a potent and selective dopamine D3 receptor agonist, with EC50 of 0.64 nM, exhibits 53-fold selectivity over dopamine D2 receptor.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorD3
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number112960-16-4
-
Formula Weight285.77
-
Molecular FormulaC14H19NO3·HCl
-
Purity98%
-
Solubility——
-
SMILESCl.[H][C@]12COC3=CC=C(O)C=C3[C@]1([H])OCCN2CCC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sautel F, et al. Neuroreport, 1995, 6(2), 329-332.
molnova catalog
related products
-
Shionone
Shionone has anti-tussive and anti-inflammatory effects.
-
5-Chlorovaleronitril...
5-Chlorovaleronitrile can be used as a quantitative structure-toxicity model to predict the aquatic toxicity.
-
8-Hydroxyguanosine
8-hydroxyguanosine (8-OHG) is a marker for measuring the rate of oxidative damage to nucleic acids and lipids.The concentration of 8-OHG in CSF in Parkinson's disease (PD) patients is approximately three-fold that in controls. The concentration of 8-OHG in CSF decreased significantly with the duration of disease. However, the concentration of 8-OHG in serum was not significantly altered in PD patients compared to that in controls.
